Advanced search
Publication Cover
ClinicoEconomics and Outcomes Research Volume 7, 2015 - Issue
Submit an article Journal homepage
125
Views
15
CrossRef citations to date
0
Altmetric
Original Research

Modeling the budget impact of long-acting injectable paliperidone palmitate in the treatment of schizophrenia in Japan

Jörg Mahlich1 Health Economics, Janssen Pharmaceutical KK, Tokyo, Japan;2 Düsseldorf Institute for Competition Economics, University of Düsseldorf, Düsseldorf, GermanyCorrespondence[email protected]
,
Masamichi Nishi3 Pricing, Janssen Pharmaceutical KK, Tokyo, Japan
&
Yoshimichi Saito1 Health Economics, Janssen Pharmaceutical KK, Tokyo, Japan
Pages 267-272 | Published online: 22 May 2015

Citations (15)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Rosarin Sruamsiri, Yasuhiro Mori & Jörg Mahlich. (2018) Productivity loss of caregivers of schizophrenia patients: a cross-sectional survey in Japan. Journal of Mental Health 27:6, pages 583-587.
Read now
Miquel Bioque & Miquel Bernardo. (2018) The current data on the 3-month paliperidone palmitate formulation for the treatment of schizophrenia. Expert Opinion on Pharmacotherapy 19:14, pages 1623-1629.
Read now
Yusuke Nakamura & Jörg Mahlich. (2017) Productivity and deadweight losses due to relapses of schizophrenia in Japan. Neuropsychiatric Disease and Treatment 13, pages 1341-1348.
Read now
Miquel Bernardo & Miquel Bioque. (2016) Three-month paliperidone palmitate - a new treatment option for schizophrenia. Expert Review of Clinical Pharmacology 9:7, pages 899-904.
Read now

Articles from other publishers (11)

Hilary PhelpsDee LinAlex KeenanAditya RajuDanmeng HuangChih-Yuan ChengCarmela Benson. (2023) Budget impact of introducing once-every-6-months paliperidone palmitate in US health care plans. Journal of Managed Care & Specialty Pharmacy 29:3, pages 303-313.
Crossref
Jörg Mahlich, Kerstin Olbrich, Adrian Wilk, Antonie Wimmer & Claus Wolff-Menzler. (2020) Time to Treatment Discontinuation in German Patients with Schizophrenia: Long-Acting Injectables versus Oral Antipsychotics. Clinical Drug Investigation 41:1, pages 99-113.
Crossref
Jörg Mahlich, Kerstin Olbrich, Adrian Wilk, Antonie Wimmer & Claus Wolff-Menzler. (2020) Hospitalization Rates and Therapy Costs of German Schizophrenia Patients Who are Initiated on Long-Acting Injectable Medication: A Mirror-Image Study. Clinical Drug Investigation 40:4, pages 355-375.
Crossref
Yusuke Nakamura, Isao Shibata & Jörg Mahlich. (2019) Modeling the Choice Between Risperidone Long-Acting Injectable and Generic Risperidone from the Perspective of a Japanese Hospital. Neurology and Therapy 8:2, pages 433-447.
Crossref
Celso Arango, Inmaculada Baeza, Miquel Bernardo, Fernando Cañas, Consuelo de Dios, Marina Díaz-Marsá, María Paz García-Portilla, Luis Gutiérrez-Rojas, José Manuel Olivares, Fernando Rico-Villademoros, Roberto Rodríguez-Jiménez, Eva María Sánchez-Morla, Rafael Segarra & Benedicto Crespo-Facorro. (2019) Long-acting injectable antipsychotics for the treatment of schizophrenia in Spain. Revista de Psiquiatría y Salud Mental (English Edition) 12:2, pages 92-105.
Crossref
Celso Arango, Inmaculada Baeza, Miquel Bernardo, Fernando Cañas, Consuelo de Dios, Marina Díaz-Marsá, María Paz García-Portilla, Luis Gutiérrez-Rojas, José Manuel Olivares, Fernando Rico-Villademoros, Roberto Rodríguez-Jiménez, Eva María Sánchez-Morla, Rafael Segarra & Benedicto Crespo-Facorro. (2019) Antipsicóticos inyectables de liberación prolongada para el tratamiento de la esquizofrenia en España. Revista de Psiquiatría y Salud Mental 12:2, pages 92-105.
Crossref
Rosarin Sruamsiri, Hiroshi Kubo & Jörg Mahlich. (2018) Hospitalization costs and length of stay of Japanese children with respiratory syncytial virus. Medicine 97:29, pages e11491.
Crossref
Mark Pennington & Paul McCrone. (2017) The Cost of Relapse in Schizophrenia. PharmacoEconomics 35:9, pages 921-936.
Crossref
Stephane Cheung, Yukinobu Hamuro, Jörg Mahlich, Takanobu Nakahara, Rosarin Sruamsiri & Sunny Tsukazawa. (2017) Drug Utilization of Japanese Patients Diagnosed with Schizophrenia: An Administrative Database Analysis. Clinical Drug Investigation 37:6, pages 559-569.
Crossref
Josephine Mauskopf, Stephanie R. Earnshaw, Anita Brogan, Sorrel Wolowacz & Thor-Henrik BrodtkorbThor-Henrik Brodtkorb, Josephine Mauskopf & Stephanie Earnshaw. 2017. Budget-Impact Analysis of Health Care Interventions. Budget-Impact Analysis of Health Care Interventions 59 69 .
. (2015) Long-acting paliperidone palmitate cost saving in Japan. PharmacoEconomics & Outcomes News 729:1, pages 21-21.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.